PASSIGE: A new gene editing technique combines prime editing and evolved recombinases for precise, efficient integration of large genes, advancing gene therapy potential.
Mitchell Lee, CEO of Ora Biomedical, is revolutionizing longevity research with high-throughput screening in C. elegans, aiming to screen over 1 million compounds in